Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Thoracic and Cardiovascular Surgery|August 26, 2022
Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non-small cell lung cancer: Results from a randomized trialBenjamin Lee, Nathan Mynard, Abu Nasar, et al.
The Annals of Thoracic Surgery|February 19, 2022
Extent of Resection Influences Survival in Early-Stage Lung Cancer With Occult Nodal DiseaseNathan Mynard, Abu Nasar, Mohamed Rahouma, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 12, 2025
All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cell lung cancerShaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, et al.
Journal of Thoracic Disease|April 15, 2024
Wedge resection, segmentectomy, and lobectomy: oncologic outcomes based on extent of surgical resection for ≤2 cm stage IA non-small cell lung cancerShaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, et al.
Respirology (Carlton, Vic.)|December 17, 2025
Robotic One Anaesthetic Marking And Resection (ROMAR): A Novel Approach for Thoracoscopic Sublobar Resection of Peripheral Pulmonary LesionsMuhammad S Ali, Dan Jones, Eugene Shostak, et al.
The Annals of Thoracic Surgery|June 26, 2016
Successful Treatment of an Iatrogenic Tracheal Laceration With a Temporary Polyurethane-Coated Nitinol StentBenjamin E Lee, Robert J Korst
The Journal of Thoracic and Cardiovascular Surgery|June 18, 2025
The extent of lymph node dissection is not associated with disease-free survival following lobar or sublobar resection: Results from Cancer and Leukemia Group B 140503 (Alliance)Nasser Altorki, Bryce Damman, Xiaofei Wang, et al.
Cancer Research|March 11, 2010
Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanibPetros G Nikolinakos, Nasser Altorki, David Yankelevitz, et al.
Clinical Lung Cancer|September 28, 2021
Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief ReportNathan Mynard, Ashish Saxena, Alexandra Mavracick, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 25, 2023
Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trialJay M Lee, Eric Vallières, Beiying Ding, et al.
Pageof 10